A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
about
The Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus SurfaceCoxsackievirus B detection in cases of myocarditis, myopericarditis, pericarditis and dilated cardiomyopathy in hospitalized patientsCharacterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines.Enterovirus infections of the central nervous system.Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis.Deletions within the 5'UTR of coxsackievirus B3: consequences for virus translation and replication.Ribosomal Initiation Complex Assembly within the Wild-Strain of Coxsackievirus B3 and Live-Attenuated Sabin3-like IRESes during the Initiation of TranslationBasic rationale, current methods and future directions for molecular typing of human enterovirus.Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditisCoxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis.Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.GLP-1-mediated gene therapy approaches for diabetes treatment.Developing a vaccine for Type 1 diabetes through targeting enteroviral infections.A novel pancreatropic coxsackievirus vector expressing glucagon-like peptide 1 reduces hyperglycemia in streptozotocin-treated mice.Recent advances from studies on the role of structural proteins in enterovirus infection.Complete genome sequence of a coxsackievirus B3 recombinant isolated from an aseptic meningitis outbreak in eastern China.An epidemic of coxsackievirus B3 infection in infants and children in Jiangsu Province, China: a prospective cohort study.Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.
P2860
Q27673022-7FC0DC81-D4E2-4C22-B1CF-8AC4ABB8BAA5Q34042122-47745020-397A-40E6-8AD8-FC3A9A4DF87EQ34093830-1466F006-4F1F-4DCC-86ED-DE325AC7FF93Q34697319-AC770034-85A1-4305-A626-157B06109DAEQ36052773-28EE4D64-2840-4B16-9782-A2C1AA1417AEQ36359523-714695C5-1174-44CA-862F-C9890BAC3F45Q36790234-E27D0B6D-6065-4941-8F24-DC9B90389553Q36874351-229D0669-0E05-41EE-AB6C-5B84E0C89F93Q36977614-A2AD5D84-60B5-4D0F-9DEC-09F802FF4D0CQ37340465-ADCEC7CB-B01B-46A1-A0CC-901A1FA6CB9FQ37620427-ABF6FF0A-3F39-4E16-9021-ABFD99714DD4Q38123714-69066779-1720-4BA4-BD2B-247516F2A3F0Q38199215-67F8400A-3010-469E-856F-EF212D65964FQ38223233-45620896-E2AC-4C42-8553-287AAA144040Q38961417-2F9B5FE1-BE97-4E5E-A2C7-00144C033353Q38966855-28E981DB-47BC-4008-BA44-56DFE338A8BEQ39728422-811F968B-3737-42EC-81AC-E1FF81DE01E9Q39884542-382ABF73-C2F4-4D25-BDA2-FE1AE95DF176Q42250118-994AD8F3-7BE1-4A10-8D6D-7398F964BBA6
P2860
A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A genetically engineered atten ...... mice against lethal infection.
@en
type
label
A genetically engineered atten ...... mice against lethal infection.
@en
prefLabel
A genetically engineered atten ...... mice against lethal infection.
@en
P2860
P1433
P1476
A genetically engineered atten ...... mice against lethal infection.
@en
P2093
P2860
P304
P356
10.1128/JVI.79.14.9285-9295.2005
P407
P577
2005-07-01T00:00:00Z